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Abstract A peptlde reproducing the G-H loop amino acid 
sequence of foot-and-mouth disease virus VP1 protein was fused 
to the solvent-exposed C-terminus of the bacteriophage P22 
tailspike protein [Carbonell and Villaverde (1996) Gene, in 
press], a homotrimeric polypeptide with a strong B-helical 
structure. This fusion does not interfere with the biological 
activities of the phage tail. The antigenic profde of the complex 
antigenic site A within the G-H loop has been determined by 
competitive ELISA with a panel of monoclonal antibodies 
directed against different overlapping B-cell epitopes. The 
antigenic data have been compared with those obtained with a 
set of 12 chiieric i3-galactosidases displaying the G-H loop on 
different exposed regions. A high coincidence has been evidenced 
between the antigenicity of the viral peptide fused to the phage 
protein and that of some peptides inserted in an exposed loop of 
the activating interface of bgalactosidase. This indicates that 
completely different structural frameworks of carrier proteins 
can provide similar constraints that allow the recombinant 
peptide to successfully mimic the antigenicity, and probably 
conformatlonal features, of the natural peptide on the virion 
surface. 
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1. Introduction 
The antigenic site A of foot-and-mouth disease virus 
(FMDV) is a small peptide of VP1 protein of about 15 amino 
acids in length and one of the major antigenic determinants of 
FMDV [l]. In serotype C, this segment contains several con- 
tinuous, overlapping B-cell epitopes [2] and is located in the 
disordered, extremely flexible G-H loop which protrudes from 
the outer capsid surface around the five-fold axis of the eico- 
sahedral structure [3,4]. This peptide also includes the argi- 
nine-glycine-aspartic acid (RGD) motif involved in cell recog- 
nition and attachment [5,6]. Critical residues in these epitopes 
have been identified by antigenic analysis of synthetic peptides 
and by sequencing both monoclonal antibody-resistant 
(MAR) mutants and field isolates [2,7,8]. On the other 
hand, amino acid substitutions within this region occur very 
frequently, thus defining a hypervariable segment that has 
been used as a model to study features of viral evolution in 
both laboratory and field conditions [9-111. 
The particular complexity of this antigenic site seems to 
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have a structural basis and this fact could be related to the 
extreme flexibility of the G-H loop, which makes it invisible in 
crystallographic studies. In fact, it has been proposed that, 
like a peptide in solution, this loop could adopt a set of con- 
formations against which different monoclonal antibodies are 
directed [12]. In agreement with this suggestion, the antigen- 
icity of a recombinant G-H loop sequence displayed on a 
chimeric protein is better than that of a lineal peptide and it 
varies upon the specific insertion site [13]. This indicates that 
the framework provided by a carrier protein can create struc- 
tural constrictions that modulate the antigenic mimicry. This 
observation could be of great interest regarding the design of 
recombinant peptides that conserve their natural activities. 
In this connection, we have explored the antigenic profile of 
the FMDV G-H loop when displayed at the C-terminus of the 
homotrimeric tailspike protein (TSP) of Salmonella bacter- 
iophage P22 [14], and compared this pattern with that of 
the same peptide presented on different regions of the P-ga- 
lactosidase surface. Interestingly, the chimeric TSP is highly 
antigenic and the viral peptide shows an antigenic profile 
similar to that observed on the virus surface, but especially 
to one among the chimeric P-galactosidases. This converging 
antigenic profile indicates that more than one particular 
framework can provide the structural requirements for an 
improved antigenic mimicry of a peptide inserted in a recom- 
binant, carrier protein. 
2. Material and methods 
2.1. Recombinant proteins and other antigens 
TSPA is a TSP in which the FMDV G-H loou Deotide from isolate 
C-S8cl (amino acids 134156) has been fused at-its’ C-terminus [15]. 
This protein has been produced from a pTrc99A (Pharmacia) deriva- 
tive by IPTG-mediated induction in E. coli BL26. Chimeric P22 par- 
ticles were obtained by in vitro association as described [15]. Most 
chimeric B-galactosidases have been previously described [16,17]. All 
of them contain the complete antigenic site A sequence (amino acids 
134-156 of protein VPl) inserted in different regions of the recombi- 
nant enzyme. ABl is an N-terminal fusion of a larger VP1 region 
including the 134-156 peptide [13]. AB1278VPl is a hybrid between 
ABl and M278VPl proteins constructed as described for AB1275VPl 
[17]. The chimeric B-galactosidases were produced in MC1061 E. coli 
strain from pJLA602 derivatives by heat induction. The concentration 
of the viral peptide in cell extracts was calculated by Western blot as 
described [13]. UV-inactivated FMDV particles and peptide A21 were 
generously provided by M.G. Mateu and D. Andreu, respectively. 
2.2. Competitive ELISA and monoclonal antibodies 
Monoclonal antibodies raised against the whole FMDV particles 
but directed to site A have been previously described [2,8]. Competi- 
tive ELISA was performed according to a previously described pro- 
tocol [18]. Peptide A21 reproduces a segment of G-H loop containing 
FMDV site A [10,13]. This peptide, coupled to KLH (AZl-KLH), was 
used as a coating antigen for microtiter plates. 5 pmol of peptide per 
well was plated and incubated overnight at 4°C in carbonate buffer. 
ELISA plates were blocked with 5% BSA in PBS for at least 2 h and 
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then washed with PBS. 95 ~1 of a solution containing non-saturating, 
fixed amounts of mAbs and different amounts of antigen (2, 6, 18, 54, 
162 and 486 nM) in 1% BSA were plated and further incubated at 
room temperature for 1 h. Non-bound antibodies were removed by 
washing with PBS+O.05% Tween. Bound mAbs were detected by using 
peroxidase-conjugated goat anti-mouse IgG (Bio-Rad) (100 ul of a 
1:3000 dilution) and developed with 4-chloro-l-naphthol and Hz02 
as substrates. The reaction was stopped with 50 ul of HzSOd 2 M and 
the absorbance read at 620 nm. 
3. Results and discussion 
3.1. Antigenicity of the FMDV peptide fused to the P22 TSP 
In a previous work, it has been shown that the FMDV G-H 
loop peptide, fused to the C-terminus of P22 TSP, is solvent- 
exposed and accessible to antibodies [15]. The antigenicity of 
soluble, homotrimeric TSPA protein was studied using a set 
of seven mAbs elicited against the whole virus particles but 
directed to different epitopes within site A. In Fig. 1A are 
depicted the results obtained in an ELISA in which TSPA 
competed with A2I-KLH peptide bound to plastic wells. 
The chimeric protein is recognized by all the mAbs with dif- 
ferent efficiencies whereas TSP is not recognized at all. In 
particular, SD6 and SBlO, which are closely related and prob- 
ably recognize the same B-cell epitope [2,18,19], show a poor 
immunoreactivity with TSPA, while the rest of the antibodies 
recognize the antigen better. Since the panel of mAbs used is 
representative of the average reactivity of sera from infected 
animals [13], this result suggests that the majority of the viral 
B-cell epitopes contained in site A are efficiently reproduced in 
the chimeric TSPA. Fig. 1B shows the reactivity of two mAbs 
with TSPA after in vivo association with tailless P22 heads. 
No significant differences of reactivity are evident between 
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head-associated and free TSPA, indicating that the interaction 
of the N-terminus of TSPA to the virus heads does not pro- 
duce alterations in the opposite C-terminus that could modify 
the solvent presentation of the antigenic site. Concentrations 
of competitor antigen leading to 50% inhibition of the max- 
imum reactivity (ICsc) were calculated for all the mAbs. 
3.2. Antigenic analysis of chimeric P-galactosidases 
Competitive ELISAs were performed to determine the anti- 
genicity of 12 chimeric B-galactosidases displaying FMDV site 
A on different insertion sites. In addition, whole virus parti- 
cles and a synthetic peptide reproducing site A were also 
studied. The obtained results allowed us to calculate, for 
each protein competing with bound A21-KLH peptide, an 
I& value (the molar amount of antigen necessary to reduce 
reactivity in ELISA to 50%). These values, similar to those 
obtained when competing with the whole virus [13], were 
compared with those presented in Fig. 1A for TSPA. For 
each antibody and protein, pairwise data were obtained and 
plotted in Fig. 2. As observed, some chimeric P-galactosidases 
react poorly with all the mAbs (see M351VPl and M962VPl), 
suggesting that in these cases, especially in M962VPl protein, 
the antigenic site A could not be completely exposed on the 
protein surface. Like TSPA, some other chimeric B-galactosi- 
dases are well recognized by most of mAbs, with the exception 
of SBlO and SD6. In these cases (see M275VP1, M275LVPl 
and to a lesser extent ABl and AB1275VPl), there is a good 
correlation between TCsa values of TSPA and mutant B-galac- 
tosidases. Note that the coincidence is in fact promoted by 
both an efficient mimicry of the epitopes recognized by 3E5, 
6Dl1, 7CA8, 7FC12 and 7JDll and a poor reproduction of 
the epitope(s) recognized by SBlO and SD6. This is indeed the 
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Fig. 1. A: Competitive ELISA with several mAbs directed to the FMDV site A, using 5 pmol of peptide A21 coupled to KLH as a bound 
antigen. The competitor antigen was soluble TSPA protein. B: Complete, infectious P22 chimeric particles containing TSPA (filled symbols) 
were used as competitors with mAbs 3E5 and 7JDl and compared with TSPA protein (empty symbols). Free A21 and non-fused TSP were 
also included as a positive and negative controls, respectively. 
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Fig. 2. A pairwise comparison between I&s (given in nM) of TSPA and different chimeric B-galactosidases in competitive ELISAs, using A21- 
KLH as a bound antigen as explained in Fig. 1. Each point represents data obtained from one of the mAbs directed against site A. Regression 
lines for each panel are also shown. Symbols besides the names of proteins indicate the significance of the correlation coefficient: **, 99%; 
*, 95%; +, 90”/0; no symbol, < 90%. Peptide A21 coupled to KLH and whole virus particles (FMDV) were also included as controls. The com- 
plete inhibition curves of chimeric B-galactosidases and control antigens will be given elsewhere (Benito et al., in preparation). 
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antigenic profile of the viral peptide in TSPA. As expected, 
the ICsss obtained with the competing whole virus particles 
have the lowest values and do not discriminate between the 
two groups of B-cell epitopes, as TSPA and some P-galacto- 
sidases do. Other recombinant proteins, such as M278VPl 
and M275SVP1, mimic the SD6SBlO epitope better than 
TPSA. 
In summary, the antigenic profile of the FMDV G-H loop, 
exposed on the virus surface, is mimicked by the viral peptide 
displayed on the C-terminus of P22 TSP. However, at least 
one B-cell epitope (SBlO-SD6) is poorly reproduced and the 
reactivity of TSPA with both antibodies is low and similar to 
that of peptides presumably not solvent-exposed (i.e. 
M962VPl). On the other hand, the antigenic structure of 
TSPA is very similar to that observed in M275VPl. In 
TSPA, the viral peptide is fused to the C-terminus of TSP. 
This region is solvent-exposed and participates in the forma- 
tion of a long P-helix turn [14]. In the C-terminus, the viral 
peptides in the interdigitated trimer are probably proximal to 
each other in the caudal fin of the TSP body [14], at the distal 
end of the P22 particle. In protein M275VP1, the viral peptide 
is inserted in a large, solvent exposed loop of the activating 
interface of B-galactosidase, which extends from one mono- 
mer to another and participates in the structure of the active 
site [20]. In this situation, the heterologous peptide seems to 
be very flexible and it might adopt a quasi-cyclic structure 
(Benito et al., unpublished results) that could be compatible 
with that observed in the reduced G-H loop on the virion 
surface [21]. Moreover, on the folded M275VPl tetramer, 
the four copies of site A cannot be physically proximal. These 
results prove that it is possible to reproduce antigenic features 
of a viral peptide by display in completely different structural 
frameworks of recombinant proteins and that the symmetric 
disposition in a multimeric carrier is not necessarily critical for 
its antigenicity. The fact that the same epitopes are lost or 
maintained in TSPA and M275VPl suggests that in the inser- 
tion sites of these two proteins, the viral segment adopts a 
functionally matching conformational spectrum. 
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